Global Access to Radiotherapy in Low- and Middle-income Countries.

Area of Science:

• Oncology
• Radiation Medicine
• Public Health

Background:

• The International Atomic Energy Agency (IAEA) has a 60-year history of improving radiotherapy services globally.
• Collaboration with partners like the World Health Organization (WHO) is crucial for cancer control in low- and middle-income countries (LMICs).
• The Lancet Oncology Commission identified key actions to expand radiotherapy access worldwide.

Purpose of the Study:

• To summarize the IAEA's role in developing radiotherapy services in LMICs.
• To highlight the IAEA's support for national infrastructure, regulatory frameworks, and human resource training.
• To demonstrate alignment with the recommendations of The Lancet Oncology Commission.

Main Methods:

• The IAEA works with LMICs to establish national infrastructure for radiation safety.
• Training programs are provided for healthcare professionals in radiation medicine.
• The agency supports the development of regulatory authorities for nuclear safety.

Main Results:

• The IAEA facilitates the introduction and expansion of high-quality radiotherapy services.
• Support extends to diagnosis, treatment, and palliative care for cancer patients.
• Efforts contribute to addressing global disparities in cancer care.

Conclusions:

• The IAEA plays a vital role in enhancing cancer diagnosis, treatment, and control in LMICs.
• Investment in infrastructure and training is essential for effective radiotherapy services.
• The IAEA's work directly supports global initiatives to improve cancer care access.